Disposition and kinetics of tetrabromobisphenol A in female Wistar Han rats

Toxicology Reports

Volumn 1, Issue , 2014, Pages 214-223

  Knudsen, Gabriel A ^a   Sanders, J Michael ^a   Sadik, Abdella M ^a   Birnbaum, Linda S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Brominated flame retardant; Disposition; Female rat; Persistent organic pollutants; TBBPA; Tetrabromobisphenol A; Tetrabromobisphenol A (PubChem CID: 6618); Toxicokinetics

Indexed keywords

CARBON 14; FLAME RETARDANT; GLUCURONIDE; SULFATE; TETRABROMOBISPHENOL A;

ABSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BOLUS INJECTION; CARCINOGENICITY; ELECTROSPRAY MASS SPECTROMETRY; ELIMINATION HALF-LIFE; EXCRETION; FECES; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; METABOLITE; NONHUMAN; PERSISTENT ORGANIC POLLUTANT; RADIOACTIVITY; RAT; SULFATION; SYSTEMIC CIRCULATION; TOXICOKINETICS; UTERUS TUMOR; WISTAR HANNOVER RAT;

EID: 84922689979     PISSN: 22147500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxrep.2014.03.005     Document Type: Article

References (41)

1. Abdallah M.A., Harrad S. Tetrabromobisphenol-A, hexabromocyclododecane and its degradation products in UK human milk: relationship to external exposure. Environ. Int. 2011, 37:443-448.
2. Andersen A., Holte H., Slordal L. Pharmacokinetics and metabolism of doxorubicin after short-term infusions in lymphoma patients. Cancer Chemother. Pharmacol. 1999, 44:422-426.
3. Antignac J.P., Cariou R., Maume D., Marchand P., Monteau F., Zalko D., Berrebi A., Cravedi J.P., Andre F., Le Bizec B. Exposure assessment of fetus and newborn to brominated flame retardants in France: preliminary data. Mol. Nutr. Food Res. 2008, 52:258-265.
4. Antunes I.F., Haisma H.J., Elsinga P.H., van Waarde A., Willemsen A.T., Dierckx R.A., de Vries E.F. In vivo evaluation of 1-O-(4-(2-fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-O-beta-d-glucopyronurona te: a positron emission tomographic tracer for imaging beta-glucuronidase activity in a tumor/inflammation rodent model. Mol. Imaging 2012, 11:77-87. E71.
5. Asano Y., Hiramoto T., Nishino R., Aiba Y., Kimura T., Yoshihara K., Koga Y., Sudo N. Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, 303:G1288-G1295.
6. Birnbaum L.S., Decad G.M., Matthews H.B. Disposition and excretion of 2,3,7,8-tetrachlorodibenzofuran in the rat. Toxicol. Appl. Pharmacol. 1980, 55:342-352.
7. BSEF TBBPA Factsheet 2012, Bromine Science and Environment Forum. http://www.bsef.com/uploads/Factsheet_TBBPA_25-10-2012.pdf.
8. Canada Risk Management Scope for Phenol, 4,4'-(1-methylethylidene) bis[2,6-dibromo-(Tetrabromobisphenol A) Chemical Abstract Service Registry Number (CAS RN): 79-94-7 2012, D.o.H. Dept. Of the Environment (Ed.).
9. Carignan C.C., Abdallah M.A., Wu N., Heiger-Bernays W., McClean M.D., Harrad S., Webster T.F. Predictors of tetrabromobisphenol-A (TBBP-A) and hexabromocyclododecanes (HBCD) in milk from Boston mothers. Environ. Sci. Technol. 2012, 46:12146-12153.
10. Cariou R., Antignac J.P., Zalko D., Berrebi A., Cravedi J.P., Maume D., Marchand P., Monteau F., Riu A., Andre F., Le Bizec B. Exposure assessment of French women and their newborns to tetrabromobisphenol-A: occurrence measurements in maternal adipose tissue, serum, breast milk and cord serum. Chemosphere 2008, 73:1036-1041.
11. Chignell C.F., Han S.K., Mouithys-Mickalad A., Sik R.H., Stadler K., Kadiiska M.B. EPR studies of in vivo radical production by 3,3',5,5'-tetrabromobisphenol A (TBBPA) in the Sprague-Dawley rat. Toxicol. Appl. Pharmacol. 2008, 230:17-22.
12. Covaci A., Harrad S., Abdallah M.A., Ali N., Law R.J., Herzke D., de Wit C.A. Novel brominated flame retardants: a review of their analysis, environmental fate and behaviour. Environ. Int. 2011, 37:532-556.
13. de Wit C.A., Herzke D., Vorkamp K. Brominated flame retardants in the Arctic environment - trends and new candidates. Sci. Total Environ. 2010, 408:2885-2918.
14. Dixon R.L., Shultice R.W., Fouts J.R. Factors affecting drug metabolism by liver microsomes. IV. Starvation. Proc. Soc. Exp. Biol. Med. 1960, 103:333-335.
15. Dotta A., Chukhlantseva N. Ontogeny and drug metabolism in newborns. J. Matern. Fetal Neonatal Med. 2012, 25(Suppl. 4):83-84.
16. Gosavi R.A., Knudsen G.A., Birnbaum L.S., Pedersen L.C. Mimicking of estradiol binding by flame retardants and their metabolites: a crystallographic analysis. Environ. Health Perspect. 2013, 121:1194-1199.
17. Hagmar L., Sjodin A., Hoglund P., Thuresson K., Rylander L., Bergman A. Biological half-lives of polybrominated diphenyl ethers and tetrabromobisphenol A in exposed workers. Organohalogen Compd. 2000, 47:198-201.
18. Hakk H., Larsen G., Bergman A., Orn U. Metabolism, excretion and distribution of the flame retardant tetrabromobisphenol-A in conventional and bile-duct cannulated rats. Xenobiotica 2000, 30:881-890.
19. Hamers T., Kamstra J.H., Sonneveld E., Murk A.J., Kester M.H., Andersson P.L., Legler J., Brouwer A. In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. Toxicol. Sci. 2006, 92:157-173.
20. Hamers T., Kamstra J.H., Sonneveld E., Murk A.J., Visser T.J., Van Velzen M.J., Brouwer A., Bergman A. Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2',4,4'-tetrabromodiphenyl ether (BDE-47). Mol. Nutr. Food Res. 2008, 52:284-298.
21. IPCS/WHO Tetrabromobisphenol A and Derivatives 1995, G. World Health Organization (Ed.).
22. Jakobsson K., Thuresson K., Rylander L., Sjodin A., Hagmar L., Bergman A. Exposure to polybrominated diphenyl ethers and tetrabromobisphenol A among computer technicians. Chemosphere 2002, 46:709-716.
23. Kang M.J., Kim J.H., Lee S.K., Kang W., Kim H.S., Lyoo W.S., Jeong T.C. A rapid method to determine tetrabromobisphenol a in rat serum and urine by liquid chromatography-tandem mass spectrometry. Arch. Pharmacal Res. 2010, 33:1797-1803.
24. Kang M.J., Kim J.H., Shin S., Choi J.H., Lee S.K., Kim H.S., Kim N.D., Kang G.W., Jeong H.G., Kang W., Chun Y.J., Jeong T.C. Nephrotoxic potential and toxicokinetics of tetrabromobisphenol A in rat for risk assessment. J. Toxicol. Environ. Health A 2009, 72:1439-1445.
25. Kitamura S., Jinno N., Ohta S., Kuroki H., Fujimoto N. Thyroid hormonal activity of the flame retardants tetrabromobisphenol A and tetrachlorobisphenol A. Biochem. Biophys. Res. Commun. 2002, 293:554-559.
26. Kitamura S., Kato T., Iida M., Jinno N., Suzuki T., Ohta S., Fujimoto N., Hanada H., Kashiwagi K., Kashiwagi A. Anti-thyroid hormonal activity of tetrabromobisphenol A, a flame retardant, and related compounds: Affinity to the mammalian thyroid hormone receptor, and effect on tadpole metamorphosis. Life Sci. 2005, 76:1589-1601.
27. Kuester R.K., Solyom A.M., Rodriguez V.P., Sipes I.G. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats. Toxicol. Sci. 2007, 96:237-245.
28. Meerts I.A., van Zanden J.J., Luijks E.A., van Leeuwen-Bol I., Marsh G., Jakobsson E., Bergman A., Brouwer A. Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicol. Sci. 2000, 56:95-104.
29. Mitchell S.J., Hilmer S.N. Drug-induced liver injury in older adults. Ther. Adv. Drug Saf. 2010, 1:65-77.
30. NTP TR-587. Technical Report Pathology Tables and Curves for TR-587: Tetrabromobisphenol A (TBBPA) 2013, National Toxicology Program, Health and Human Services, Found at: http://ntp.niehs.nih.gov/go/38602.
31. Riu A., Grimaldi M., le Maire A., Bey G., Phillips K., Boulahtouf A., Perdu E., Zalko D., Bourguet W., Balaguer P. Peroxisome proliferator-activated receptor gamma is a target for halogenated analogs of bisphenol A. Environ. Health Perspect. 2011, 119:1227-1232.
32. Riu A., le Maire A., Grimaldi M., Audebert M., Hillenweck A., Bourguet W., Balaguer P., Zalko D. Characterization of novel ligands of ERalpha, Erbeta, and PPARgamma: the case of halogenated bisphenol A and their conjugated metabolites. Toxicol. Sci. 2011, 122:372-382.
33. Samuelsen M., Olsen C., Holme J.A., Meussen-Elholm E., Bergmann A., Hongslo J.K. Estrogen-like properties of brominated analogs of bisphenol A in the MCF-7 human breast cancer cell line. Cell Biol. Toxicol. 2001, 17:139-151.
34. Schauer U.M., Volkel W., Dekant W. Toxicokinetics of tetrabromobisphenol a in humans and rats after oral administration. Toxicol. Sci. 2006, 91:49-58.
35. Shi Z.-X., Wu Y.-N., Li J.-G., Zhao Y.-F., Feng J.-F. Dietary exposure assessment of Chinese adults and nursing infants to tetrabromobisphenol-A and hexabromocyclododecanes: occurrence measurements in foods and human milk. Environ. Sci. Technol. 2009, 43:4314-4319.
36. Shi Z., Jiao Y., Hu Y., Sun Z., Zhou X., Feng J., Li J., Wu Y. Levels of tetrabromobisphenol A, hexabromocyclododecanes and polybrominated diphenyl ethers in human milk from the general population in Beijing, China. Sci. Total Environ. 2013, 452-453:10-18.
37. Szymanska J.A., Piotrowski J.K., Frydrych B. Hepatotoxicity of tetrabromobisphenol-A: effects of repeated dosage in rats. Toxicology 2000, 142:87-95.
38. Szymanska J.A., Sapota A., Frydrych B. The disposition and metabolism of tetrabromobisphenol-A after a single i.p. dose in the rat. Chemosphere 2001, 45:693-700.
39. Uhnakova B., Ludwig R., Peknicova J., Homolka L., Lisa L., Sulc M., Petrickova A., Elzeinova F., Pelantova H., Monti D., Kren V., Haltrich D., Martinkova L. Biodegradation of tetrabromobisphenol A by oxidases in basidiomycetous fungi and estrogenic activity of the biotransformation products. Bioresour. Technol. 2011, 102:9409-9415.
40. Van der Ven L.T., Van de Kuil T., Verhoef A., Verwer C.M., Lilienthal H., Leonards P.E., Schauer U.M., Canton R.F., Litens S., De Jong F.H., Visser T.J., Dekant W., Stern N., Hakansson H., Slob W., Van den Berg M., Vos J.G., Piersma A.H. Endocrine effects of tetrabromobisphenol-A (TBBPA) in Wistar rats as tested in a one-generation reproduction study and a subacute toxicity study. Toxicology 2008, 245:76-89.
41. Zalko D., Prouillac C., Riu A., Perdu E., Dolo L., Jouanin I., Canlet C., Debrauwer L., Cravedi J.P. Biotransformation of the flame retardant tetrabromo-bisphenol A by human and rat sub-cellular liver fractions. Chemosphere 2006, 64:318-327.